Angiotensin receptor and endothelin receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KX Antihypertensives for pulmonary arterial hypertension
C02KX02 Ambrisentan
D07077 Ambrisentan (JAN/INN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Pulmonary Antihypertensives
Endothelin Receptor Antagonists
Ambrisentan
D07077 Ambrisentan (JAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D07077 Ambrisentan (JAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01502 Endothelin receptor antagonist
D07077 Ambrisentan
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Endothelin
EDNRA
D07077 Ambrisentan (JAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D07077
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D07077
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D07077
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D07077